294 related articles for article (PubMed ID: 12472796)
1. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?
Zeier M; Schwenger V; Deppisch R; Haug U; Weigel K; Bahner U; Wanner C; Schneider H; Henle T; Ritz E
Kidney Int; 2003 Jan; 63(1):298-305. PubMed ID: 12472796
[TBL] [Abstract][Full Text] [Related]
2. Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content.
Schmitt CP; von Heyl D; Rieger S; Arbeiter K; Bonzel KE; Fischbach M; Misselwitz J; Pieper AK; Schaefer F;
Nephrol Dial Transplant; 2007 Jul; 22(7):2038-44. PubMed ID: 17420168
[TBL] [Abstract][Full Text] [Related]
3. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
[TBL] [Abstract][Full Text] [Related]
5. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.
Williams JD; Topley N; Craig KJ; Mackenzie RK; Pischetsrieder M; Lage C; Passlick-Deetjen J;
Kidney Int; 2004 Jul; 66(1):408-18. PubMed ID: 15200450
[TBL] [Abstract][Full Text] [Related]
6. Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.
Ishikawa N; Miyata T; Ueda Y; Inagi R; Izuhara Y; Yuzawa H; Onogi H; Nishina M; Nangaku M; Van Ypersele De Strihou C; Kurokawa K
Kidney Int; 2003 Jan; 63(1):331-9. PubMed ID: 12472800
[TBL] [Abstract][Full Text] [Related]
7. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis.
Linden T; Cohen A; Deppisch R; Kjellstrand P; Wieslander A
Kidney Int; 2002 Aug; 62(2):697-703. PubMed ID: 12110035
[TBL] [Abstract][Full Text] [Related]
8. Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid.
Inagi R; Miyata T; Ueda Y; Yoshino A; Nangaku M; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2002 Aug; 62(2):679-87. PubMed ID: 12110033
[TBL] [Abstract][Full Text] [Related]
9. 3,4-DGE in peritoneal dialysis fluids cannot be found in plasma after infusion into the peritoneal cavity.
Erixon M; Wieslander A; Lindén T; Carlsson O; Jönsson JA; Simonsen O; Kjellstrand P
Perit Dial Int; 2008; 28(3):277-82. PubMed ID: 18474921
[TBL] [Abstract][Full Text] [Related]
10. 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids infused into the peritoneal cavity cannot be found in plasma.
Erixon M; Wieslander A; Lindén T; Carlsson O; Jönsson JA; Simonsen O; Kjellstrand P
Perit Dial Int; 2009 Feb; 29 Suppl 2():S28-31. PubMed ID: 19270226
[TBL] [Abstract][Full Text] [Related]
11. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.
Schalkwijk CG; Posthuma N; ten Brink HJ; ter Wee PM; Teerlink T
Perit Dial Int; 1999; 19(4):325-33. PubMed ID: 10507813
[TBL] [Abstract][Full Text] [Related]
12. The influence of bicarbonate/lactate-buffered PD fluids on N{ε}-(carboxyethyl)lysine and N{ε}-(carboxymethyl)lysine in peritoneal effluent.
Cnossen TT; Gladziwa U; van de Kerkhof JJ; Schalkwijk CG; Scheijen J; van Amersfoort J; Moret K; Beerenhout CH; Kooman JP
Perit Dial Int; 2011; 31(2):189-93. PubMed ID: 20671103
[TBL] [Abstract][Full Text] [Related]
13. Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids.
Distler L; Georgieva A; Kenkel I; Huppert J; Pischetsrieder M
Chem Res Toxicol; 2014 Aug; 27(8):1421-30. PubMed ID: 25033248
[TBL] [Abstract][Full Text] [Related]
14. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
[TBL] [Abstract][Full Text] [Related]
15. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
[TBL] [Abstract][Full Text] [Related]
16. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study.
Haag-Weber M; Krämer R; Haake R; Islam MS; Prischl F; Haug U; Nabut JL; Deppisch R;
Nephrol Dial Transplant; 2010 Jul; 25(7):2288-96. PubMed ID: 20197284
[TBL] [Abstract][Full Text] [Related]
17. Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis.
Tauer A; Bender TO; Fleischmann EH; Niwa T; Jörres A; Pischetsrieder M
Mol Nutr Food Res; 2005 Jul; 49(7):710-5. PubMed ID: 15915443
[TBL] [Abstract][Full Text] [Related]
18. "NEPP" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO.
le Poole CY; van Ittersum FJ; Valentijn RM; Teerlink T; Lindholm B; Ter Wee PM; Schalkwijk CG
Perit Dial Int; 2012; 32(1):45-54. PubMed ID: 21632443
[TBL] [Abstract][Full Text] [Related]
19. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
20. Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture.
Simonsen O; Sterner G; Carlsson O; Wieslander A; Rippe B
Perit Dial Int; 2006; 26(3):353-9. PubMed ID: 16722029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
